₹937.50
+14.30 (+1.55%)
As of 17 Oct 2026, Shilpa Medicare Ltd share price is ₹937.50. The stock opened at ₹937.50 and had closed at ₹923.20 the previous day. Over the last 52 weeks, the stock has recorded a low of ₹260.00 and a high of ₹1,095.65. In terms of performance, Shilpa Medicare Ltd share price has increased by 129.92% over the past six months and has increased by 159.59% over the last year.
SHILPAMED Stock Price Chart
Shilpa Medicare Ltd Overview
Market cap₹18,336 Crs
Volume1,79,093
Prev. Close₹923.20
Year range₹260.00 - ₹1,095.65
ISININE790G01031
About SHILPAMED
Shilpa Medicare engaged in the manufacturing of API, Formulation and Development service.
Shilpa Medicare Ltd Historical Performance
1 Month Return1.06%
6 Month Return127.96%
3 Year Return454.41%
3 Month Return46.96%
1 Year Return162.02%
5 Year Return203.10%
Shilpa Medicare Ltd Fundamentals
ROCE(TTM)4.87%
P/E Ratio (TTM)100.37
P/B Ratio6.76
Debt to Equity0.05
ROE4.26%
EPS (TTM)8.01
Dividend Yield0.06%
Book Value138.73
Profit Margin22.69%
Operating Margin18.72%
Shilpa Medicare Ltd Financials
| Indicator | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Revenue | 635.17 | 547.08 | 398.91 | 316.34 | 397.81 |
| EBITDA | 213.28 | 160.06 | 104.96 | 9.10 | 71.36 |
| Net Profit | 132.97 | 67.89 | 26.94 | 57.19 | 140.99 |
| EPS | 6.80 | 6.97 | 3.10 | 6.59 | 16.87 |
Shilpa Medicare Ltd Technical Analysis
| Indicator | Value |
|---|---|
| Support 1 (S1) | 904.48 |
| Resistance 1 (R1) | 955.43 |
| Pivot Point | 936.72 |
Shilpa Medicare Ltd Dividend History
| Ex Date | Dividends Date | Record Date | Dividend Type | Dividend Details |
|---|---|---|---|---|
| 04-Sep-2026 | 22-May-2026 | 04-Sep-2026 | Final | ₹0.60 |
| 17-Sep-2025 | 26-May-2025 | 17-Sep-2025 | Final | ₹1.00 |
| 19-Sep-2022 | 23-May-2022 | 20-Sep-2022 | Final | ₹1.10 |
| 20-Sep-2021 | 31-May-2021 | 22-Sep-2021 | Final | ₹1.10 |
SHILPAMED Key Leadership Details
Last Updated: Mar 2026
| Name | Position |
|---|---|
| Omprakash Inani | Chairman |
| Vishnukant Bhutada | Managing Director |
| Hetal Gandhi | Non Executive Independent Director |
Shilpa Medicare Ltd Peer Comparison
| Company | Price | M.Cap (Cr) | P/E (TTM) | ROE (TTM) |
|---|---|---|---|---|
| Sun Pharmaceutical Industries LtdSUNPHARMA | ₹1,758.80-0.29% | ₹4,19,727.66 | 38.32 | 13.74% |
| Divis Laboratories LtdDIVISLAB | ₹9,144.50+1.27% | ₹1,67,235.91 | 67.46 | 15.32% |
| Torrent Pharmaceuticals LtdTORNTPHARM | ₹4,558.90-0.55% | ₹1,46,951.32 | 64.68 | 25.49% |
Disclaimer
The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...
Frequently Asked Questions
- The share price of Shilpa Medicare Ltd today is ₹937.50 on NSE and ₹937.50 on BSE.
- The 52-week high of Shilpa Medicare Ltd is ₹1,095.65, while the 52-week low is ₹260.00.
- The current market capitalisation of Shilpa Medicare Ltd is approximately ₹18,336 crore.
- The P/E (Price-to-Earnings) ratio of Shilpa Medicare Ltd is 41.18. The ratio may vary with changes in the share price and earnings.
- The P/B (Price-to-Book) ratio of Shilpa Medicare Ltd is 2.53. It compares the company’s market value with its book value and can provide an indication of how the market values the company relative to its net assets.
- To buy Shilpa Medicare Ltd shares, you first need to open a demat account before you can place an order. Here's the process:
• Open a demat account online using your PAN, Aadhaar and bank details.
• Add funds to your trading account via UPI or net banking.
• Search for SHILPAMED on TradeMobi or the Anand Rathi web platform.
• Place your order
• Track your holdings in the portfolio section. - Over the past 3 years, Shilpa Medicare Ltd has delivered a return of approximately 454.41%. This return is based on the change in the share price over the specified period and may differ depending on the measurement date. Past performance does not guarantee future returns.
- The shareholding pattern of Shilpa Medicare Ltd comprises different categories of shareholders. As of Sept 2026, the shareholding is approximately 40.13% promoters, 7.91% FIIs, 8.26% DIIs, and 27.73% public shareholders.

